Heightened Genetic Disease Risk Linked to Remote Regions in the U.K.
Individuals from isolated parts of the U.K. could have variations in their genetic code that increase their chance of developing certain diseases, according to a new study “Regionally enriched rare deleterious exonic variants in...
CRISPR-edited fungus boosts protein production and cuts environmental impact
In a new study publishing November 19 in the Cell Press journal Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to increase a fungus's production efficiency and cut its production-related environmental impact...
What’s old is new again
Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance
Credit: Image/Art credit: Mark Miller, Stowers Institute
KANSAS CITY, MO–Drug resistance is a major obstacle in cancer treatment–leading...
PacBio to commence first customer shipments of Revio long-read sequencing systems
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023. As previously announced, the Revio system features...
New funding advances AI-powered technology to track therapeutic and diseased cells
Targeting and treating diseases first requires being able to find specific cells-which is challenging because they travel within the body and can "hide."
Now, a new round of funding will support advancing technology invented at...
Engineered E. coli shows promise in cancer immunotherapy
Study title: Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell therapy
Publication: Nature Biotechnology
Dana-Farber Cancer Institute authors: Rizwan Romee, MD, Shaobo Yang, Michal Sheffer, PhD, David Barbie, MD, Catherine Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD
New CRISPR-based tool can snip out faulty genes and replace them with new ones
Building on the CRISPR gene-editing system, MIT researchers have designed a new tool that can snip out faulty genes and replace them with new ones, in a safer and more efficient way.
Using this system,...
Biden Launches Initiative to Expand Market for Plastic Alternatives – One Green Planet
$ billed upfront every .
$ billed upfront every .
$ billed upfront for one time.
<!--
Lorum imsum lorum ipsum
--> Source
Study highlights the potential of cell replacement therapy for Huntington’s disease
New research appearing in the journal Nature Biotechnology answers important questions about the viability of treatments that seek to replace diseased and aged cells in the central nervous system with healthy ones. Its findings...
First COVID-19 vaccine found to be safe, able to generate rapid immune response in...
Reviewed by Emily Henderson, B.Sc.May 22 2020
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...
